P. Sevigny

Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.

M. Inganäs, J. Hansson, U. Ringborg, 1997, Journal of the National Cancer Institute.

Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease.

J. Poirier, P. Sévigny, Judes Poirier, 1998, Journal of neural transmission. Supplementum.

Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases.

T. Norberg, U. Ringborg, A. Platz, 1996, British Journal of Cancer.

Construction of cloning vectors using the Vibrio harveyi luminescence genes luxA and luxB as markers.

F. Gossard, P. Sévigny, P. Sevigny, 1990, Gene.

Further evidence for a synergistic association between APOEɛ4 and BCHE-K in confirmed Alzheimer’s disease

H. Wiebusch, K. Schappert, J. Poirier, 1999, Human Genetics.

Pharmacogenetics of Psychotropic Drugs: Apolipoprotein E as a marker in the treatment of Alzheimer's disease

K. Schappert, J. Poirier, P. Sevigny, 2002 .